Skip to search formSkip to main contentSkip to account menu

epaxal berna

Known as: epaxal 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Hepatitis A Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Micro- and Nanoparticulate Cancer Vaccines: A Vision for the Future
In lieu of an abstract, here is the article's first paragraph: Formulation scientists are constantly challenged with unique… 
2015
2015
Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents
Although the overall incidence of hepatitis A in Korea has been decreasing, adolescents remain highly vulnerable to its outbreaks… 
2015
2015
Seropositivity among Korean Young Adults Approximately 2 Years after a Single-Dose Vaccination against Hepatitis A Virus
We previously observed 80.7% seropositivity and a significant interaction between gender and hepatitis A virus (HAV) vaccine type… 
2011
2011
Successful Memory Response following a Booster Dose with a Virosome-Formulated Hepatitis A Vaccine Delayed Up to 11 Years
ABSTRACT Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a… 
2011
2011
Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children.
2007
2007
Immunogenicity and safety of a virosomal hepatitis A vaccine in HIV-positive patients.
2004
2004
Rapid Antibody Response after Vaccination with a Virosomal Hepatitis A Vaccine
Abstract.Background:This study was designed to assess the early antibody kinetics after a priming dose, and the extent of the… 
Review
2002
Review
2002
New technology platforms in the development of vaccines for the future.
The desire for improved quality of life in both industrialised and under-developed nations has led to the quest for greater… 
1999
1999
Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccines.
BACKGROUND The purpose of this study was to evaluate the tolerance and immunogenicity of a hepatitis A vaccine using… 
Review
1995
Review
1995
Hepatitis A vaccine
Hepatitis A is a self-limiting inflammation of the liver, which is caused by the hepatitis A virus. The infection is rare in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)